Quaker Wealth Management
WST icon

Quaker Wealth Management’s West Pharmaceutical WST Stock Holding History

Quaker Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$371 Hold
1
– – ﹤0.01% 767
2026
Q2 		$359 Hold
1
– – ﹤0.01% 808
2026
Q1 		$251 Sell
1
-1
-50% -$249 ﹤0.01% 848
2025
Q4 		$551 Hold
2
– – ﹤0.01% 672
2025
Q3 		$525 Buy
2
+1
+100% +$243 ﹤0.01% 590
2025
Q2 		$219 Buy
+1
New +$214 ﹤0.01% 794

Other funds holding WST

Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
North Growth Management
North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Quaker Wealth Management's WST Position: Q3 2026 in Review

Quaker Wealth Management held its West Pharmaceutical (WST) position steady in Q3 2026 at 1 share worth $371. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Quaker Wealth Management first reported a position in WST in Q2 2025 and has held it in 6 quarters since. The position peaked at $551 in Q4 2025. 175 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Quaker Wealth Management held 1 share of West Pharmaceutical worth $371 as of Q3 2026.
  • Quaker Wealth Management left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #767 holding.
  • Quaker Wealth Management first reported a position in West Pharmaceutical in Q2 2025 and has held it in 6 quarters since.
  • Quaker Wealth Management's West Pharmaceutical position peaked at $551 in Q4 2025.
  • 175 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.